MedTrace Logo

Novel Epidermal Recording and Detection of Seizures

NCT02451618 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2018-09-07

No results posted yet for this study

Summary

For any newborn that exhibits possible seizure activity or has altered mental status of unknown etiology, continuous bedside EEG recording is the standard of care to detect subclinical seizure activity. The experimental aspect of this study will be the application of test electrodes (EES or EKG) to evaluate if the electrodes can be used to produce a continuous bedside recording of brain activity in the same manner as an EEG recording, while ideally producing less irritation of newborn skin than conventional EEG electrodes.

Conditions

  • Seizures
  • Encephalopathy
  • Asphyxiated Newborn

Sponsors & Collaborators

  • The Gerber Foundation

    collaborator OTHER

  • Sharp HealthCare

    lead OTHER

Principal Investigators

  • Mary J Harbert, MD · Sharp Mary Birch Hospital for Women & Newborns

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-27
Primary Completion
2017-11-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02451618 on ClinicalTrials.gov